Clinical Trials Related Content
NIH begins clinical trial for Epstein-Barr virus vaccine
The clinical trial will test an Epstein-Barr virus vaccine developed by Novavax, one of just two attempts in over a decade.
Ivermectin does not stop risk of COVID hospitalisation
According to a large study, ivermectin does not protect virus patients from the risk of COVID hospitalisation - performing the same as the placebo.
Powerful new COVID treatment cuts hospital deaths by 55%
So far, there is no treatment for severe cases - but now, clinical trials for a new COVID treatment show immense promise in preventing death.
Scientists develop Omicron variant vaccine against COVID
MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.
Scientists create non-hormonal male birth control
Scientists made progress on the implementation of male birth control, which could someday split contraceptive responsibility between all genders.
TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Clinical trials begin for three mRNA HIV vaccines
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.
Real-world evidence set to turbo boost personalised healthcare
Richard Armstrong, head of registries at NEC Software Solutions UK, puts real-world evidence under the microscope and examines how, as our population ages it has the power to speed up medical interventions at scale.
New potential therapy for aggressive bladder cancer
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Scientists discover new treatment to fight pancreatic cancer
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
New gene-silencing drug could help with ALS
New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.
Early detection of pancreatic cancer – The EUROPAC Research Trial
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about the European pancreatic cancer early detection trial (EUROPAC).
Can cannabidiol treat Type 2 diabetes?
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
Osteogenesis imperfecta – what we need to know
Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.
Proving the effectiveness of digital health technologies
Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.
Merck says “COVID pill” can decrease risk of death by 50%
Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.
NIH funds menstrual cycle and COVID vaccine research
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
What is Osteogenesis Imperfecta (OI)?
Patricia Osborne, Chief Executive of the Brittle Bone Society, tells us what we need to know about Osteogenesis Imperfecta.
Moderna create vaccine trial for children aged 6 months and over
Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.
Study with one million vaccinated people finds AstraZeneca is safe
The study, pre-printed in The Lancet, found that blood clots were far more common in people with COVID-19 than people vaccinated with AstraZeneca.